PURE Bioscience (OTCMKTS:PURE) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

PURE Bioscience (OTCMKTS:PURE)’s stock price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.0819. PURE Bioscience shares last traded at $0.0818, with a volume of 90,571 shares traded.

PURE Bioscience Stock Up 4.6%

The company has a 50-day moving average of $0.06 and a 200 day moving average of $0.06. The stock has a market capitalization of $9.71 million, a PE ratio of -2.89 and a beta of 0.52.

PURE Bioscience (OTCMKTS:PURE) last announced its quarterly earnings data on Monday, March 16th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.44 million during the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.

PURE’s product suite includes concentrate formulations and ready-to-use solutions.